Y-mAbs Therapeutics (YMAB) Insider Trading & Ownership

$13.82

-0.17 (-1.22%)

(As of 09/6/2024 ET)

Current Insider Ownership Percentage: 21.50%
Number Of Insiders Buying (Last 12 Months): 2
Amount Of Insider Buying (Last 12 Months): $1.41 M
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $2.36 M

Get YMAB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Y-mAbs Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

YMAB Insider Buying and Selling by Quarter

Ad Porter & Company

War on Elon Escalates…

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Y-mAbs Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/26/2024	Joris Wilms	COO	Sell	5,000	$14.69	$73,450.00
6/10/2024	Gerard Ber	Director	Sell	722	$12.00	$8,664.00
6/10/2024	Thomas Gad	Insider	Sell	35,000	$12.03	$421,050.00
5/31/2024	Bo Kruse	CFO	Sell	31,371	$12.07	$378,647.97
5/23/2024	Thomas Gad	Insider	Sell	7,351	$13.00	$95,563.00
5/21/2024	Thomas Gad	Insider	Sell	25,000	$12.00	$300,000.00
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
3/5/2024	Vignesh Rajah	SVP	Sell	1,711	$16.53	$28,282.83
12/15/2023	Thomas Gad	Insider	Sell	50,000	$6.61	$330,500.00
12/13/2023	Thomas Gad	Insider	Sell	50,000	$6.58	$329,000.00
12/11/2023	Biotech Aps Wg	Director	Buy	102,863	$7.01	$721,069.63
12/7/2023	Biotech Aps Wg	Director	Buy	6,183	$6.50	$40,189.50
11/29/2023	Biotech Aps Wg	Director	Buy	51,837	$5.97	$309,466.89
11/27/2023	Johan Wedell-Wedellsborg	Director	Buy	62,516	$5.49	$343,212.84
11/20/2023	Thomas Gad	Insider	Sell	75,000	$5.30	$397,500.00

(Data available from 1/1/2013 forward)

YMAB Insider Trading Activity - Frequently Asked Questions

Who is on Y-mAbs Therapeutics's Insider Roster?: The list of insiders at Y-mAbs Therapeutics includes Biotech Aps Wg, Bo Kruse, Gerard Ber, Johan Wedell-Wedellsborg, Joris Wilms, Thomas Gad, and Vignesh Rajah. Learn more on insiders at YMAB.
What percentage of Y-mAbs Therapeutics stock is owned by insiders?: 21.50% of Y-mAbs Therapeutics stock is owned by insiders. Learn more on YMAB's insider holdings.
Which Y-mAbs Therapeutics insiders have been buying company stock?: The following insiders have purchased YMAB shares in the last 24 months: Biotech Aps Wg ($1,070,726.02), Johan Wedell-Wedellsborg ($1,325,003.84), and Vignesh Rajah ($5,879.40).

How much insider buying is happening at Y-mAbs Therapeutics?: Insiders have purchased a total of 326,334 YMAB shares in the last 24 months for a total of $2,401,609.26 bought.
Which Y-mAbs Therapeutics insiders have been selling company stock?: The following insiders have sold YMAB shares in the last 24 months: Bo Kruse ($378,647.97), Gerard Ber ($8,664.00), Joris Wilms ($73,450.00), Thomas Gad ($1,873,613.00), and Vignesh Rajah ($28,282.83).
How much insider selling is happening at Y-mAbs Therapeutics?: Insiders have sold a total of 281,155 Y-mAbs Therapeutics shares in the last 24 months for a total of $2,362,657.80 sold.